BRD2 and neoplasm: To characterize a comprehensive molecular landscape in AEG tumors, we applied multi-omics profiling to the paired tumor and NAT samples from 103 patients (Supplementary Data 1), including proteomics profiling, phosphoproteomics profiling, WES, and RNA-seq (Fig. 1a).